The market professionals have placed average price target of $83.04 on Quest Diagnostics Incorporated (NYSE:DGX) stock. This target, which is projected to be hit in 1-year, is totaled mean of analyst calls covered in First Call industry survey. Quarterly earnings is predicted at $1.29 a share and for fiscal it is $5.11.
Quest Diagnostics Incorporated technical analysis substantiates that Quest Diagnostics Incorporated 50-day moving average is at $83.76, and it is trading $-0.34 points away or -0.40% from its 50-day MA of $83.76. It is trading $3.42 or +4.28% away its 200-day moving average of $80.00. Quest Diagnostics Incorporated (NYSE:DGX) 52-week high is $86.85 and the 52-week low is $59.66.
If the stock moves $-3.43, it will upright hit a 52-week high. In episode of +39.83% plunge, a 52-week low is in scope.
Market price discounts all the factors that can impact securities price. It indicates the market price of a stock at any given point accurately shows all available information, so shows the fair value of the stock. This assumption is dependent on the concept the market price continuously reveals the sum total information of all market contributors.
Quest Diagnostics Incorporated (NYSE:DGX) P/E ratio came in at 14.56. The stock closed at $83.42 in last trading session, so current market cap is $11.60B.
John Templeton says to purchase bargains, meaning, buy equities when they trade at best value. When the index is at a low, shareholders discover the best bargains. More precisely, it indicates when the P/E ratio is low, investors experience strong returns by purchasing equities. Stocks should be sold into when P/E ratios are at higher end of scale. That makes perfect sense, as the stock value and the market rises when the P/E ratio increases. Purchasing when the P/E ratio of market is at a high level raises the peril that investors will witness negative return, while purchasing when the P/E ratio is low considerably increases the probability investors will experience lucrative returns in the succeeding years. Quest Diagnostics Incorporated (NYSE:DGX) PEG ratio is at 2.15.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...